Immunotherapy of CD30-expressing lymphoma using a highly stable ssDNA aptamer.
about
Multivalent Aptamers: Versatile Tools for Diagnostic and Therapeutic ApplicationsssDNA Aptamer Specifically Targets and Selectively Delivers Cytotoxic Drug Doxorubicin to HepG2 CellsDNA Aptamer Technology for Personalized Medicine.SL2B aptamer and folic acid dual-targeting DNA nanostructures for synergic biological effect with chemotherapy to combat colorectal cancer.Selection of Nucleic Acid Aptamers Targeting Tumor Cell-Surface Protein BiomarkersDrug-Free Macromolecular Therapeutics--A New Paradigm in Polymeric NanomedicinesAptamers for respiratory syncytial virus detection.Oligonucleotide aptamers: new tools for targeted cancer therapy.Aptamer Internalization via Endocytosis Inducing S-Phase Arrest and Priming Maver-1 Lymphoma Cells for Cytarabine Chemotherapy.Specific and sensitive tumor imaging using biostable oligonucleotide aptamer probes.Biostable ssDNA aptamers specific for Hodgkin lymphomaAptamers and their applications in nanomedicine.A Highlight of Recent Advances in Aptamer Technology and Its Application.Aptamers: versatile molecular recognition probes for cancer detection.Oligonucleotide aptamer-drug conjugates for targeted therapy of acute myeloid leukemia.In vitro selections of mammaglobin A and mammaglobin B aptamers for the recognition of circulating breast tumor cells.Self-Assembled Aptamer-Nanomedicine for Targeted Chemotherapy and Gene Therapy.A single-round selection of selective DNA aptamers for mammalian cells by polymer-enhanced capillary transient isotachophoresis.Aptamer Technology: Adjunct Therapy for Malaria.Engineered Aptamers to Probe Molecular Interactions on the Cell Surface.Engineering nanoparticles to overcome barriers to immunotherapy.Selection of a novel CD19 aptamer for targeted delivery of doxorubicin to lymphoma cells.
P2860
Q28073119-01EC13AD-AC34-461A-A4A1-6E12E562EF14Q28552859-562E2B20-5FE8-420B-8ED2-D84A3FE3251EQ30412965-5E64162C-8881-4574-AF53-F909C6DEF450Q33553679-43BF68FC-BA79-44AE-8D1B-C38A8918BFC7Q33832781-BEB4506B-F235-41AE-9143-17824122E877Q35861726-8F0E5557-92F7-4C1F-B6F6-B5A8293F23A9Q37654797-89522FC5-2069-47E2-AB52-6AD8B44A4114Q38237132-E399CD81-05BA-4EAF-B579-82330B41D9DDQ38288291-4639A818-4CB8-49E3-90AD-411122C4B1BDQ38305533-511C1D97-96D8-4CEC-91D6-041238DE864CQ38311211-6D88FE16-F308-4CB7-B247-0456E3E6A08DQ38353973-28479942-5DA3-4D64-A9F4-53E510A62E50Q38541697-B32894F9-B460-455F-BA54-04DD547EE7A1Q38652995-5B1313B2-ABB3-4582-AD0D-AC5F967C2204Q38850054-CD688B62-F417-4404-8CA6-00819A8B7E41Q45753940-DA3AA190-97F6-4A13-A5EE-E9B0D439828FQ45875443-FCEA11E9-850E-4A16-8986-BC3440FD2630Q47712658-E9FFDD58-CE6A-46DD-93CC-75BD8BBF811BQ52093966-8671CDA8-4730-4A1E-8839-29E34E6AD4A9Q53092802-6393DDEE-1E03-4DE4-AEE8-049EC48B57B4Q54991276-6EF01F85-E604-4710-AFD6-C5BABE8D080DQ55250617-1BDD4808-8207-4DE1-86B0-9B07A03077BA
P2860
Immunotherapy of CD30-expressing lymphoma using a highly stable ssDNA aptamer.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Immunotherapy of CD30-expressing lymphoma using a highly stable ssDNA aptamer.
@en
Immunotherapy of CD30-expressing lymphoma using a highly stable ssDNA aptamer.
@nl
type
label
Immunotherapy of CD30-expressing lymphoma using a highly stable ssDNA aptamer.
@en
Immunotherapy of CD30-expressing lymphoma using a highly stable ssDNA aptamer.
@nl
prefLabel
Immunotherapy of CD30-expressing lymphoma using a highly stable ssDNA aptamer.
@en
Immunotherapy of CD30-expressing lymphoma using a highly stable ssDNA aptamer.
@nl
P2093
P2860
P1433
P1476
Immunotherapy of CD30-expressing lymphoma using a highly stable ssDNA aptamer.
@en
P2093
Bryce P Portier
Nianxi Zhao
Parag Parekh
Sanchit Kamble
Zihua Zeng
P2860
P304
P356
10.1016/J.BIOMATERIALS.2013.07.099
P577
2013-08-19T00:00:00Z